These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 20379545)
41. Synthesis of Pt@Fe2O3 nanorods as MRI probes for in vivo application. Li Y; Lu Y; Hong H; Chen Y; Ma X; Guo L; Wang Z; Chen J; Zhu M; Ni J; Gu H; Lu J; Ying JY Chem Commun (Camb); 2011 Jun; 47(22):6320-2. PubMed ID: 21541416 [TBL] [Abstract][Full Text] [Related]
42. Mechanism of proton relaxation for enzyme-manipulated, multicomponent gold-magnetic nanoparticle chains. Jaganathan H; Gieseck RL; Hudson K; Kellogg M; Ramaswamy AK; Raver KE; Smith T; Vacchiano AN; Wager A; Ivanisevic A Chemphyschem; 2010 Dec; 11(17):3664-72. PubMed ID: 21077085 [TBL] [Abstract][Full Text] [Related]
43. Iron oxide based MR contrast agents: from chemistry to cell labeling. Laurent S; Boutry S; Mahieu I; Vander Elst L; Muller RN Curr Med Chem; 2009; 16(35):4712-27. PubMed ID: 19903138 [TBL] [Abstract][Full Text] [Related]
44. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery. Talelli M; Rijcken CJ; Lammers T; Seevinck PR; Storm G; van Nostrum CF; Hennink WE Langmuir; 2009 Feb; 25(4):2060-7. PubMed ID: 19166276 [TBL] [Abstract][Full Text] [Related]
45. Aqueous dispersions of magnetite nanoparticles with NH3+ surfaces for magnetic manipulations of biomolecules and MRI contrast agents. Shieh DB; Cheng FY; Su CH; Yeh CS; Wu MT; Wu YN; Tsai CY; Wu CL; Chen DH; Chou CH Biomaterials; 2005 Dec; 26(34):7183-91. PubMed ID: 15964622 [TBL] [Abstract][Full Text] [Related]
46. Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T₂ Contrast Agents for MRI. Martínez-González R; Estelrich J; Busquets MA Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27472319 [TBL] [Abstract][Full Text] [Related]
48. Gold nanoparticles functionalized with gadolinium chelates as high-relaxivity MRI contrast agents. Moriggi L; Cannizzo C; Dumas E; Mayer CR; Ulianov A; Helm L J Am Chem Soc; 2009 Aug; 131(31):10828-9. PubMed ID: 19722661 [TBL] [Abstract][Full Text] [Related]
49. Lanthanide complexes on Ag nanoparticles: designing contrast agents for magnetic resonance imaging. Siddiqui TS; Jani A; Williams F; Muller RN; Vander Elst L; Laurent S; Yao F; Wadghiri YZ; Walters MA J Colloid Interface Sci; 2009 Sep; 337(1):88-96. PubMed ID: 19527906 [TBL] [Abstract][Full Text] [Related]
50. The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system. Bjørnerud A; Johansson L NMR Biomed; 2004 Nov; 17(7):465-77. PubMed ID: 15526351 [TBL] [Abstract][Full Text] [Related]
51. [Experiment and analyse on the effect of magnetic nanoparticles upon relaxation time of proton in molecular recognition by MRI]. Hu L; Song T; Yang W; Wang M; Zhang F; Tao C Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Jun; 24(3):590-4, 614. PubMed ID: 17713268 [TBL] [Abstract][Full Text] [Related]
52. Target-specific paramagnetic and superparamagnetic micelles for molecular MR imaging. Straathof R; Strijkers GJ; Nicolay K Methods Mol Biol; 2011; 771():691-715. PubMed ID: 21874503 [TBL] [Abstract][Full Text] [Related]
53. Cellular magnetic resonance imaging using superparamagnetic anionic iron oxide nanoparticles: applications to in vivo trafficking of lymphocytes and cell-based anticancer therapy. Smirnov P Methods Mol Biol; 2009; 512():333-53. PubMed ID: 19347287 [TBL] [Abstract][Full Text] [Related]
55. Metallic iron nanoparticles for MRI contrast enhancement and local hyperthermia. Hadjipanayis CG; Bonder MJ; Balakrishnan S; Wang X; Mao H; Hadjipanayis GC Small; 2008 Nov; 4(11):1925-9. PubMed ID: 18752211 [No Abstract] [Full Text] [Related]
56. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging. Stoll G; Bendszus M Neuroscience; 2009 Feb; 158(3):1151-60. PubMed ID: 18651996 [TBL] [Abstract][Full Text] [Related]
57. Microgel iron oxide nanoparticles for tracking human fetal mesenchymal stem cells through magnetic resonance imaging. Lee ES; Chan J; Shuter B; Tan LG; Chong MS; Ramachandra DL; Dawe GS; Ding J; Teoh SH; Beuf O; Briguet A; Tam KC; Choolani M; Wang SC Stem Cells; 2009 Aug; 27(8):1921-31. PubMed ID: 19544438 [TBL] [Abstract][Full Text] [Related]
58. Layer-by-layer capsules for magnetic resonance imaging and drug delivery. Ai H Adv Drug Deliv Rev; 2011 Aug; 63(9):772-88. PubMed ID: 21554908 [TBL] [Abstract][Full Text] [Related]
59. [Transmission electron microscopy in the structural study of superparamagnetic contrast agents for MRI]. Lucet I; Filmon R; Pouliquen D; Le Jeune JJ; Jallet P Bull Assoc Anat (Nancy); 1994 Mar; 78(240):57-9. PubMed ID: 7519906 [TBL] [Abstract][Full Text] [Related]